GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM, being > 100-fold selective for IGF-1R/InsR than Akt1/2, Aurora A/B,B-Raf, CDK2, EGFR etc.
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | IGF-1R ↓ ↑ | Insulin Receptor ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMS-536924 | ++ IGF-1R, IC50: 100 nM | +++ Insulin Receptor, IC50: 73 nM | FAK,MEK | 98% | |||||||||||||||
| GSK1904529A | +++ IGF-1R, IC50: 27 nM | +++ Insulin Receptor, IC50: 25 nM | 98+% | ||||||||||||||||
| Picropodophyllin | ++++ IGF-1R, IC50: 1 nM | 99%+ | |||||||||||||||||
| NVP-AEW541 | ++ IGF-1R, IC50: 0.15 μM | ++ Insulin Receptor, IC50: 0.14 μM | FLT3 | 99%+ | |||||||||||||||
| NVP-ADW742 | + IGF-1R, IC50: 0.17 μM | 98% | |||||||||||||||||
| GSK1838705A | +++ IGF-1R, IC50: 2 nM | ++++ Insulin Receptor, IC50: 1.6 nM | ALK | 98% | |||||||||||||||
| BMS-754807 | ++++ IGF-1R, IC50: 1.8 nM | ++++ Insulin Receptor, IC50: 1.7 nM | 99%+ | ||||||||||||||||
| Linsitinib | +++ IGF-1R, IC50: 35 nM | ++ Insulin Receptor, IC50: 75 nM | 99%+ | ||||||||||||||||
| AG1024 | + IGF-1R, IC50: 7 μM | + Insulin Receptor, IC50: 57 μM | 98% | ||||||||||||||||
| PQ401 | + IGF-1R, IC50: <1 μM | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 | 
 | 
| 描述 | IGF-1R (insulin-like growth factor-1 receptor) plays a key role in transformation, growth and survival of malignant cells, and has been considered as a general and promising target for cancer treatment. GSK1904529A is a selective inhibitor of IGF-IR and IR with IC50 values of 27 and 25nM, respectively. Treatment with GSK1904529A ranging in 0.03-3μM dose-dependently inhibited IGF-1- or insulin-induced autophosphorylation of IGF-1R, as well as the downstream signaling, including phosphorylation of ATK, IRS-1 and ERK. And this inhibition on phosphorylation on IGF-1R and its downstream can be also observed in vivo. In COLO 205, MCF-7, and NCI-H929 cells treated with GSK1904529A ranging in 0.3-10μM for 24h or 48h, dose-dependent increased accumulation in G1 of the cell cycle could be observed. GSK1904529A showed anti-proliferation of cell lines derived from solid and hematologic malignancies, among which multiple myeloma and Ewing’s sarcoma cell lines showed most sensitivity. Oral administration of GSK1904529A at 30mg/kg once daily or twice daily for 21 days significantly inhibited tumor growth inhibition of female nude mice bearing tumor xenografts of NIH-3T3/LISN, COLO 205, HT29 and BxPC3, respectively. As GSK1904529A is also a IR inhibitor, minimal effects on blood glucose levels can be observed in animals treated with a single dose of 30 mg/kg GSK1904529A[1]. | 
| 作用机制 | GSK1904529A is a reversible, ATP-competitive inhibitor.[1] | 
| 细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 | 
| human COLO205 cells | Proliferation assay | 72 h | Antiproliferative activity against human COLO205 cells after 72 hrs by Celltiter assay, IC50=124 nM | 19101143 | |
| human LP-1 cells | Proliferation assay | 72 h | Antiproliferative activity against human LP-1 cells after 72 hrs by Celltiter assay, IC50=104 nM | 19101143 | |
| human NCI-H929 cells | Proliferation assay | 72 h | Antiproliferative activity against human NCI-H929 cells after 72 hrs by Celltiter assay, IC50=81 nM | 19101143 | |
| human SK-ES cells | Proliferation assay | 72 h | Antiproliferative activity against human SK-ES cells after 72 hrs by Celltiter assay, IC50=61 nM | 19101143 | |
| Dose | Mice: 30 mg/kg[1] (p.o.) | 
| Administration | p.o. | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 1.17mL 0.23mL 0.12mL | 5.87mL 1.17mL 0.59mL | 11.74mL 2.35mL 1.17mL | |
| CAS号 | 1089283-49-7 | 
| 分子式 | C44H47F2N9O5S | 
| 分子量 | 851.96 | 
| SMILES Code | O=C(C1=CC(C2=C(N3C=CC=CC3=N2)C4=NC(NC5=CC(CC)=C(C=C5OC)N6CCC(CC6)N7CCN(CC7)S(=O)(C)=O)=NC=C4)=CC=C1OC)NC8=C(C=CC=C8F)F | 
| MDL No. | MFCD17010271 | 
| 别名 | GSK 4529 | 
| 运输 | 蓝冰 | 
| InChI Key | MOSKATHMXWSZTQ-UHFFFAOYSA-N | 
| Pubchem ID | 25124816 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C | 
| 溶解方案 | DMSO: 50 mg/mL(58.69 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1